News    Please click the Current Issue button above to return to the contents page
 
Kentucky governor signs death warrant despite medical association guidance
 
Can medical students learn empathy at the movies?
 
Doctor's are leaving the UK
 
First Pharmfree day launched
 
Raising horizons
 
Medics worldwide: news and oppurtunities from the IFMSA
 
Write a response to this article
 
Email this article to a friend
   


First Pharmfree Day launched

By Raghav Chawla, BMJ

The first nationwide Pharmfree Day has been launched by The American Medical Student Association on 8 December 2004.

Doctors and students joined together on more than 34 campuses, urging their peers to resist aggressive marketing efforts by pharmaceutical companies. "Prescribing should be based on clinical evidence not on marketing strategies," Brian Palmer, president of the association, told the studentBMJ.

An event was held at New York University with speakers such as Gene Carbona, former regional manager for Merck, and Bob Goodman, founder of No Free Lunch, an organisation of healthcare providers devoted to combating the influence of pharmaceutical promotion on clinical practice.

Dr Carbona said Merck paid doctors up to $20 000 (£10 404; a15 062) for holding a speech designed to promote its drugs. "Just think about how you would feel if your patient asked you, 'Did you put me on Vioxx [rofecoxib] because you speak for Merck?' " he asked the audience.

Dr Goodman said students had the longest "prescribing life" and were key targets for pharmaceutical representatives. He suggested that all medical schools' curriculums should include education on pharmaceutical marketing practices.

Mr Palmer told the studentBMJ that drug companies spend $25bn a year--30% of their total revenues in the United States alone--to advertise their products, which significantly increases drug prices. "We're not against pharmaceutical companies," Kim Becker, the association's spokeswoman, added. "What we're saying is that... [the money] should [instead] go into the research and development."

"So far, no pharmaceutical companies have reacted to these happenings," Mr Palmer said. The studentBMJ repeatedly phoned up Pfizer's headquarters to get their viewpoint. Nobody was available for an official statement, however.

See http://www.amsa.org/prof/activities.cfm for more information.

studentBMJ 2005;13:1-44 January ISSN 0966-6494

Printer friendly       Download PDF       Email page       Rapid Response

Click here for more information
 
 

Write a response to an article

Guidelines: We intend publishing within 24 hours all responses that contribute substantially to the topic under discussion. To avoid points that have already been made please read other people's responses before posting your own. All responses will be eligible for publication in the paper studentBMJ, providing that current appointment and place of work are given. Name and email address are required to send a response and will be published with the response.

Please note: When writing a respnse to a response, please enter the original title of the article and the author of the response you are responding to.

Name:
      
Email:
      
Current appointment / course, year:
      
Place of work / study:
      
Suggested title for your response:
      
Name of article, author and issue number:
      

Your Response: